SCHEMBL907541

SCHEMBL907541

CC[C@@H]1CC(C)(C)C[C@@](C)(N2CCCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659116 1.00
SCHEMBL657546 1.00
SCHEMBL657547 1.00
SCHEMBL5549710 1.00
SCHEMBL659299 1.00
SCHEMBL5548794 1.00
SCHEMBL16321798 0.98
SCHEMBL14833275 0.98
SCHEMBL14833352 0.98
SCHEMBL16321799 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9453017-B2 Antiviral therapies with phospholipase D inhibitors VANDERBILT UNIVERSITY (US) 2016-09-27 US claimed
EP-1682109-B1 THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES MERZ PHARMA GMBH & CO KGAA (DE) 2008-10-15 EP claimed
US-20060205822-A1 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect FOREST LABORATORIES, INC. (US) 2006-09-14 US claimed
US-20170319611-A1 METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS UNIV VANDERBILT (US) 2017-11-09 US disclosed
US-20170027885-A1 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS MERZ PHARMA GMBH & CO. KGAA (DE) 2017-02-02 US disclosed
US-9498450-B2 1-aminocyclohexane derivatives for the treatment of cochlear tinnitus MERZ PHARMA GMBH & CO. KGAA (DE) 2016-11-22 US disclosed
US-9468610-B2 1-aminocyclohexane derivatives for the treatment of hearing loss MERZ PHARMA GMBH & CO. KGAA (DE) 2016-10-18 US disclosed
US-9453017-B2 Antiviral therapies with phospholipase D inhibitors VANDERBILT UNIVERSITY (US) 2016-09-27 US disclosed
EP-2386299-B1 1-Amino-Alkylcyclohexane derivatives for use in the treatment of tinnitus associated with hearing loss MERZ PHARMA GMBH & CO KGAA (DE) 2016-07-13 EP disclosed
EP-2548552-B1 Titration package for 1-amino-alkylcyclohexanes MERZ PHARMA GMBH & CO KGAA (DE) 2015-11-18 EP disclosed
US-20150025041-A1 ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS VANDERBILT UNIVERSITY (US) 2015-01-22 US disclosed
US-20090081259-A1 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect MERZ PHARMA GMBH & CO. KGAA (DE) 2009-03-26 US disclosed
WO-2009033652-A1 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS MERZ PHARMA GMBH & CO. KGAA (DE) 2009-03-19 WO disclosed
US-20070105961-A1 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists MERZ PHARMA GMBH & CO. KGAA (DE) 2007-05-10 US disclosed
EP-1228052-B1 1-CYCLIC AMINO-ALKYLCYCLOHEXANE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE AS ANTICONVULSANTS MERZ PHARMA GMBH & CO KGAA (DE) 2007-05-02 EP disclosed
US-20060205822-A1 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect FOREST LABORATORIES, INC. (US) 2006-09-14 US disclosed
EP-1318800-B1 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS MERZ PHARMA GMBH & CO KGAA (DE) 2005-01-26 EP disclosed
US-6602862-B1 1-Amino-alkylcyclohexanes as trypanocidal agents MERZ PHARMA GMBH & CO., KGAA (DE) 2003-08-05 US disclosed
EP-1228052-A1 1-CYCLIC AMINO-ALKYLCYCLOHEXANE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE AS ANTICONVULSANTS Merz Pharmaceuticals GmbH (DE) 2002-08-07 EP disclosed
WO-2001032640-A1 1-CYCLIC AMINO-ALKYLCYCLOHEXANE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE AS ANTICONVULSANTS MERZ PHARMACEUTICALS GMBH (DE) 2001-05-10 WO disclosed